5360953
Last Update Posted: 2025-01-07
Recruiting
All Genders accepted | 18 Years-65 Years |
189 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Treating Nightmares in Posttraumatic Stress Disorder with Clonidine and Doxazosin
This randomized controlled trial will test the hypothesis that oral Clonidine or Doxazosin improves nightmares (primary outcome), other PTSD symptoms and psychopathology (secondary outcomes) to a greater extent than placebo over a ten week intervention phase in a parallel group design.
Eligibility
Relevant conditions:
Posttraumatic Stress Disorder
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov